Casdin CapitalInvestor Details

Get alertedif Casdin Capital makes an investment
Casdin Capital
Industry:Other
Want to know when Casdin Capital invests in a new company?
Portfolio:
Cedilla Therapeutics (2021: $82,600,000 raised)
Loop Medical (2021: $6,400,000 raised)
Exo Therapeutics (2021: $78,000,000 raised)
Trialspark (2021: $156,000,000 raised)
Zentera Therapeutics (2021: $75,000,000 raised)
Genomatica (2021: $118,000,000 raised)
Umoja Biopharma (2021: $210,000,000 raised)
C2i Genomics (2021: $100,000,000 raised)
Ventus Therapeutics (2021: $100,000,000 raised)
Tenaya Therapeutics (2021: $106,000,000 raised)
Vividion Therapeutics Inc (2021: $135,000,000 raised)
Verve Therapeutics (2021: $94,000,000 raised)
Paige (2021: $100,000,000 raised)
Octave Bioscience (2020: $32,000,000 raised)
Somalogic Inc (2020: $121,000,000 raised)
A2 Biotherapeutics (2020: $72,000,000 raised)
Thrive Earlier Detection Corp (2020: $257,000,000 raised)
Dna Script (2020: $60,913,200 raised)
Verve Therapeutics (2020: $63,000,000 raised)
Kallyope Inc (2020: $112,000,000 raised)
Amunix Pharmaceuticals Inc (2020: $73,000,000 raised)
Verana Health (2020: $100,000,000 raised)
Eqrx (2020: $200,000,000 raised)
Black Diamond Therapeutics (2019: $85,000,000 raised)
Tenaya Therapeutics (2019: $92,000,000 raised)
Sexton Biotechnologies (2019: $5,000,000 raised)
Revolution Medicines Inc (2019: $100,000,000 raised)
Thrive Earlier Detection Corp (2019: $110,000,000 raised)
Vividion Therapeutics Inc (2019: $82,000,000 raised)
Prominex (2018: $4,000,000 raised)
Genomatica (2018: $90,000,000 raised)
Fulcrum Therapeutics (2018: $80,000,000 raised)
Alector Llc (2018: $133,000,000 raised)
Lyra Health Inc (2018: $45,000,000 raised)
Revolution Medicines Inc (2018: $56,000,000 raised)
Vineti (2018: $33,500,000 raised)
Constellation Pharmaceuticals Inc (2018: $100,000,000 raised)
Magenta Therapeutics (2018: $52,000,000 raised)
Relay Therapeutics (2017: $63,000,000 raised)
Neon Therapeutics (2017: $36,000,000 raised)
Magenta Therapeutics (2017: $50,000,000 raised)
Syros Pharmaceuticals (2016: $40,000,000 raised)
Gritstone Oncology (2015: $102,000,000 raised)
908 Devices Inc (2015: $1,400,000 raised)
Jounce Therapeutics (2015: $56,000,000 raised)
Voyager Therapeutics (2015: $60,000,000 raised)
Invitae Corp (2014: $120,000,000 raised)
Blueprint Medicines (2014: $25,000,000 raised)
Foundation Medicine Inc (2012: $42,500,000 raised)
Coinvestors:
Nextech Invest Ltd
Section 32
Third Rock Ventures Llc
The Column Group
Redmile Group
Bvf Partners
Alexandria Venture Investments
Deerfield Management
Gv
Versant Ventures
ARCH Venture Partners
Boxer Capital Llc
Cormorant Asset Management
Foresite Capital
Polaris Partners
Ra Capital Management
Access Industries
Driehaus Capital Management Llc
Euclidean Capital
Fidelity Management & Research Company
Gv (formerly Google Ventures)
Logos Capital
Orbimed
Perceptive Advisors Llc
Schroder Adveq
Viking Global Investors
Wellington Management
6 Dimensions Capital
Biomatics Capital
Deerfield Management Company
Ecor1 Capital
Farallon Capital Management Llc
Frazier Healthcare Partners
Google Ventures
Illumina Ventures
Invus
Lux Capital
Omega Funds
Partner Fund Management Lp
Pharmstandard International
Roche Venture Fund
Rock Springs Capital
Rtw Investments
Samsara Biocapital
T Rowe Price Associates Inc
Venrock
Wellington Management Company Llp
Abbvie Ventures
Acuta Capital
Agilent Technologies
Aisling Capital
Alexandria Real Estate Equities Inc
Altitude Life Science Ventures
Amgen Ventures
Andreessen Horowitz Llc
Arboretum Ventures
Arrowmark
Arrowmark Partners
Atlas Venture
Avidity Partners
Avoro Capital Advisors
Bain Capital Life Sciences
Bain Capital Ventures Llc
Be The Match Biotherapies
Bill Gates
Biocrossroads Inc
Biolife Solutions
Biotech Value Fund Lp
Biotechnology Value Fund
Blue Water Life Science Advisors
Bluecross Blueshield Venture Partners
Bpifrance Large Venture
Brook Byers
Brookside Capital
Brown Advisory
Camden Partners
Canaan
Cardinal Partners
Celgene
City Hill Ventures
Clarus Ventures
Cook Regentec
Cormorant Capital
Cowin Venture
Crown Venture Fund
Crv
DFJ
Danaher Life Sciences
Dcvc Bio
Decheng Capital
Deerfield
Define Ventures
Delian Capital
Dragoneer
Duquesne Family Office
Echo Health Ventures
Eli Lilly
Eventide Asset Management
Exact Sciences
F-prime Capital
Federated Kaufmann Fund
Felicis Ventures Llc
Fidelity
Fidelity Management
Fiscus Ventures
Fonds De Solidarité Ftq
Gamma 3 Llc
Ge Ventures
Genesys Capital
Genomic Health Inc
Ginkgo Bioworks
Glynn Capital Management
Greenspring Associates
Hartford Healthcare Endowment
Hillhouse Capital
Hillhouse Capital Group
Iglobe Partners
Intermountain Ventures
Janus Henderson Investors
Johnson & Johnson Innovation – Jjdc Inc
Kleiner Perkins Caufield & Byers
Lifeforce Capital
Lilly Asia Ventures
Lilly Asia Ventures (lav)
Lionbird
Longitude Capital
Lsp
Madryn Asset Management
Merck Ventures
Mirae Asset Capital
Monashee Investment Management Llc
Moore Strategic Ventures
Morningside
Mossrock Capital Llc
Mpm Capital
Mrl Ventures
Mubadala Capital
Mubadala Ventures
New Enterprise Associates
New Leaf Venture Partners Llc
Newpath Partners
Nextech Inves
Nextech Venture
Nfx
Northpond Ventures
Novartis Venture Fund
Novo Holdings
Ns Investment
Ns Investments Llc
Oncology Focused Investor
Orbimed Advisors Asia
Ortho Clinical Diagnostics
Partners Innovation Fund
Presight Capital
Providence Ventures Llc
Qiming Venture Partners Usa
Reimagined Ventures
Research Company
Sands Capital
Sanofi Venture
Sarstedt Group
Sequoia Capital
Silver Lake
Sirona Capital
Softbank Investment Advisers
Softbank Vision Fund 2
Soleus Capital
Sound Ventures
Spark Capital
Srone
Surveyor Capital
Surveyor Capital (a Citadel Company)
T.rowe Price Associates Inc
Temasek
Tenaya Capital
The Blue Venture Fund
The Broe Group
The Dementia Discovery Fund
The Emerson Collective
The Mark Foundation For Cancer Research
Thermo Fisher Scientific Inc
Thomas Mcnerney & Partner
Thrive Capital
Topspin Partners
Transformational Healthcare Opportunity
Trinitas Capital
Two River
Two Sigma Ventures
Tybourne Capital Management
Uc Investments
Venrock Healthcare Partners
Vida Ventures
Vivo Capital
Watermill Asset Management
Wellington Management Co
Wellington Management Company
Woodline Partners Lp
Wuxi Corporate Venture Fund
Wuxi Ventures Funds
This list displays investors that took part in the same funding round as Casdin Capital since March 2012. They are displayed in decreasing order of coinvesting frequency.
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!